Abstract 6261: Inflammation-related exposures and histotype- specific ovarian cancer risk in the Ovarian Cancer Association Consortium (OCAC).
Abstract Background: Chronic inflammation is implicated in ovarian carcinogenesis, but how different inflammation-related exposures individually or jointly affect histotype-specific associations remains unclear. Materials and Methods: We pooled data from 16 case-control studies in the Ovarian Cancer Association Consortium to evaluate associations of eight inflammation-related factors (anti-inflammatory: aspirin use, tubal ligation (TL); pro-inflammatory: endometriosis, obesity, lifetime ovulatory cycles (LOC), smoking, pelvic inflammatory disease (PID), polycystic ovary syndrome (PCOS)) with epithelial ovarian cancer (OvC) by histologic subtype. We examined individual associations and clustering of risk factors across histotypes and computed population attributable risk (PAR) for each factor. We assessed additive and multiplicative interactions for exposure combinations. Results: Associations with OvC risk differed by histotype (e.g., high-grade serous: aspirin: OR=0.90; 95%CI 0.82, 0.99; TL: OR=0.80; 95%CI 0.73, 0.88; overall serous: endometriosis: OR=1.17; 95%CI 1.03, 1.31; high LOC: OR=1.42; 95%CI 1.28, 1.58; obesity (low-grade serous): OR=1.50; 95%CI 1.14, 1.98). Clustering analyses showed highly correlated risk profiles in endometrioid and clear cell (r=0.91). High-grade serous and mucinous profiles were moderately correlated with endometrioid and clear cell (r=0.60) tumors. The profile for low-grade serous (r=0.36) tumors was distinct from other histotypes. PAR estimates suggested modifying aspirin use, TL, and LOCs could substantially reduce burdens of endometrioid, clear cell and mucinous tumors. Out of 28 exposure combinations tested in overall OvC and 189 by histotype, we observed 12 interactions. Not using aspirin regularly showed positive additive interactions with obesity and high LOCs, particularly in endometrioid tumors (obesity relative excess risk due to interaction (RERI)=0.74, 95%CI 0.31, 1.18; Pint=0.001 for; LOCs RERI=0.80, 95%CI 0.03, 1.56; Pint=0.04). Not using aspirin regularly also showed a positive additive interaction with endometriosis in clear cell tumors (RERI=1.77, 95%CI 0.03, 3.52; Pint=0.05). Lack of TL showed positive interactions with obesity in endometrioid (RERI=0.86, 95%CI 0.17, 1.53; Pint=0.01) and mucinous (RERI=1.10, 95%CI 0.23, 1.97; Pint=0.01) tumors, while negative additive interactions were observed for smoking and endometriosis in endometrioid tumors (RERI=-1.12, 95%CI -2.19, -0.05; Pint=0.04). A multiplicative interaction was observed between obesity and endometriosis in mucinous tumors (Pint=0.01). Conclusion: The findings suggest ovarian tumorigenesis is strongly shaped by pro- and anti-inflammatory pathways that act largely independently. Further examining these pathways may clarify the origins of histotype heterogeneity and guide prevention strategies. Citation Format: Maxwell Akonde, Britton Trabert, SHELLEY TWOROGER, Allan Jensen, Kathryn L. Terry, Joshua Sampson, Hoda Anton-Culver, David Bowtell, Elisa V. Bandera, Angela Brooks-Wilson, Andrew Berchuck, Daniel William Cramer, Linda S. Cook, Julie M. Cunningham, Jennifer A. Doherty, Ellen L. Goode, Marc T. Goodman, Holly Ruth Harris, Susanne K. Kjaer, Nhu Le, Alice Wen-Ron Lee, Francesmary Modugno, Kirsten B. Moysich, Celeste Pearce, Malcolm C. Pike, Harvey A. Risch, Mary A. Rossing, Joellen M. Schildkrau, Daniel O. Stram, Rebecca Sutphen, David Van Den Berg, Penelope M. Webb, Anna Wu, Argyrios Ziogas, Nicolas A. Wentzensen. Inflammation-related exposures and histotype- specific ovarian cancer risk in the Ovarian Cancer Association Consortium (OCAC) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6261.
Authors
- Julie M. Cunningham (ORCID: https://orcid.org/0000-0002-8159-3025)
- Harvey A. Risch (ORCID: https://orcid.org/0000-0001-5337-3941)
- Elisa V. Bandera (ORCID: https://orcid.org/0000-0002-8789-2755)
- Linda S. Cook (ORCID: https://orcid.org/0000-0001-8641-0710)
- Ellen L. Goode (ORCID: https://orcid.org/0000-0002-9094-8326)
- Penelope M. Webb (ORCID: https://orcid.org/0000-0003-0733-5930)
- Anna M. Wu (ORCID: https://orcid.org/0000-0001-8487-823X)
- Marc T. Goodman (ORCID: https://orcid.org/0000-0002-4839-3021)
- Daniel O. Stram (ORCID: https://orcid.org/0000-0001-7099-9022)
- Britton Trabert (ORCID: https://orcid.org/0000-0002-1539-6090)
- Joshua N. Sampson (ORCID: https://orcid.org/0000-0003-2875-3365)
- Kathryn L. Terry (ORCID: https://orcid.org/0009-0002-5848-4661)
- Maxwell Akonde (ORCID: https://orcid.org/0000-0002-0869-1219)
- Nicolas Wentzensen (ORCID: https://orcid.org/0000-0003-1251-0836)
- Malcolm C. Pike (ORCID: https://orcid.org/0000-0003-4891-1199)
- A. Berchuck
- David Van Den Berg (ORCID: https://orcid.org/0000-0002-8797-8217)
- D. Bowtell
- Rebecca Sutphen
- Hoda Anton-Culver
- Joellen M. Schildkrau
- Allan Jensen
- A. Ziogas
- A. W. Lee
- Angela Brooks-Wilson
- Holly Ruth Harris
- Shelley S. Tworoger
- Nhu Le
- Mary A. Rossing
- Daniel William Cramer
- Kirsten B. Moysich
- Francesmary Modugno
- Celeste Pearce
- Jennifer A. Doherty
- Susanne K. Kjaer
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Southern California (US)
- Cedars-Sinai Medical Center (US)
- Brigham and Women's Hospital (US)
- BC Cancer Agency (CA)
- Roswell Park Comprehensive Cancer Center (US)
- Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
- Mayo Clinic (US)
- California State University, Fullerton (US)
- Emory University (US)
- Colorado School of Public Health (US)
- Oregon Health & Science University (US)
- University of California, Irvine (US)
- QIMR Berghofer Medical Research Institute (AU)
- University of Utah (US)
- University of South Florida (US)
- Peter MacCallum Cancer Centre (AU)
- Huntsman Cancer Institute (US)
- Spinal Cord Injury BC (CA)
- Kettering University (US)
- University of New Haven (US)
- Fred Hutch Cancer Center (US)
- Magee-Womens Research Institute (US)
- Occupational Cancer Research Centre (CA)
- Michigan United (US)
- National Cancer Institute (UA)
- Mayo Clinic in Arizona (US)
- Duke Medical Center (US)
- National Cancer Institute (MY)
- National Cancer Institute (US)
- Cancer Genetics (United States) (US)
- Danish Cancer Society (DK)
- Canadian Centre for Applied Research in Cancer Control (CA)
- Rutgers Cancer Institute (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Cancer Research
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1158/1538-7445.am2026-6261
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00